Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

Three common Apolipoprotein E isoforms, ApoE2, ApoE3, and ApoE4, are key regulators of lipid homeostasis, among other functions. Apolipoprotein E can interact with amyloid proteins. The isoforms differ by one or two residues at positions 112 and 158, and possess distinct structural conformations and...

Full description

Bibliographic Details
Main Authors:	Rolf Antonie Loch, Hongzhi Wang, Alex Perálvarez-Marín, Philipp Berger, Henrietta Nielsen, Angeliki Chroni, Jinghui Luo
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	ApoE Amyloid proteins Interaction Endogenous molecules Cytotoxicity Therapeutics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037023000223

Similar Items

Associations of endogenous estrogens, plasma Alzheimer’s disease biomarkers, and APOE4 carrier status on regional brain volumes in postmenopausal women
by: Katrina A. Wugalter, et al.
Published: (2024-07-01)

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
by: Monica Xiong, et al.
Published: (2023-03-01)

Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review
by: Aikaterini Theodorou, et al.
Published: (2021-01-01)

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease
by: Grace M. Lloyd, et al.
Published: (2020-03-01)

Chemotherapy promotes astrocytic response to Aβ deposition, but not Aβ levels, in a mouse model of amyloid and APOE
by: Christi Anne S. Ng, et al.
Published: (2022-12-01)

In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more
by: Christian Behl
Published: (2024-09-01)

Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
by: Jerome Robert, et al.
Published: (2020-03-01)

Apolipoprotein E genotype is associated with island sign in lobar intracerebral hemorrhage
by: Qiong Yang, et al.
Published: (2025-02-01)

Evaluation of Apolipoprotein B / Apolipoprotein A Ratio as an Alternate of Lipid Profile for Cardiovascular Risk Assessment in a Tertiary Care Hospital
by: Aqsa Mushtaq, Muhammad Younas, Zujaja Hina Haroon, Muhammad Usman Munir, Sayed Tanveer Abbas Gilani, Muhammad Anwar
Published: (2024-03-01)

Association of liver function markers and apolipoprotein E ε4 with pathogenesis and cognitive decline in Alzheimer’s disease
by: Sang-Won Han, et al.
Published: (2024-07-01)

Sensitivity of the African neuropsychology battery memory subtests and learning slopes in discriminating APOE 4 and amyloid pathology in adult individuals in the Democratic Republic of Congo
by: Jean Ikanga, et al.
Published: (2024-03-01)

Gray matter gamma‐hydroxy‐butyric acid and glutamate reflect beta‐amyloid burden at old age
by: Simon J. Schreiner, et al.
Published: (2024-04-01)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
by: Sid E. O'Bryant, et al.
Published: (2022-06-01)

The association of apolipoprotein in the risk of ST-elevation myocardial infarction in patients with documented coronary artery disease
by: Astuti Giantini, et al.
Published: (2023-09-01)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
by: Kazushi Suzuki, et al.
Published: (2020-01-01)

Endogenous Human Proteins Interfering with Amyloid Formation
by: Anna L. Gharibyan, et al.
Published: (2022-03-01)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
by: Min Seok Baek, et al.
Published: (2020-10-01)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
by: Hyuk Sung Kwon, et al.
Published: (2023-10-01)

Applications of Single-Molecule Vibrational Spectroscopic Techniques for the Structural Investigation of Amyloid Oligomers
by: Katrin Ha Phuong Vu, et al.
Published: (2022-09-01)

Library screening identifies commercial drugs as potential structure correctors of abnormal apolipoprotein A-I
by: Christina Gkolfinopoulou, et al.
Published: (2024-05-01)

Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer
by: Chenxi Li, et al.
Published: (2025-01-01)

Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications
by: Sarah J. Doran, et al.
Published: (2024-01-01)

Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy
by: Yoshinori Endo, et al.
Published: (2019-01-01)

Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults
by: Robin de Flores, et al.
Published: (2023-06-01)

Serum apolipoprotein B to apolipoprotein A‐I ratio predicts mortality in patients with heart failure
by: Shiyang Li, et al.
Published: (2024-02-01)

Effects of toxic apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in neonatal mice under sevoflurane anesthesia
by: Yang Yu, et al.
Published: (2022-08-01)

Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42
by: Kyung-Hyun Cho
Published: (2021-07-01)

ASSOCIATION OF CAROTID INTIMA-MEDIA THICKNESS WITH LEPTIN AND APOLIPOPROTEIN B/APOLIPOPROTEIN A-I RATIO REVEALS IMMINENT PREDICTORS OF SUBCLINICAL ATHEROSCLEROSIS IN PSORIASIS PATIENTS
by: Kumari Asha, et al.
Published: (2014-01-01)

DNA nanostructures prevent the formation of and convert toxic amyloid proteospecies into cytocompatible and biodegradable spherical complexes
by: Nadjib Kihal, et al.
Published: (2024-06-01)

Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients
by: Hyuk Sung Kwon, et al.
Published: (2025-03-01)

Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients
by: José A. Fernández, et al.
Published: (2020-02-01)

Apolipoprotein E is required for brain iron homeostasis in mice
by: Juan Ma, et al.
Published: (2023-08-01)

Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research
by: Alberto Granzotto, et al.
Published: (2024-09-01)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
by: Stephanie R. Oatman, et al.
Published: (2023-01-01)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
by: Elles Konijnenberg, et al.
Published: (2020-05-01)

Pathways to Alzheimer’s Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health
by: Alexandru Laslo, et al.
Published: (2024-10-01)

Circulating growth differentiation factor 15 levels and apolipoprotein B to apolipoprotein A1 ratio in coronary artery disease patients with type 2 diabetes mellitus
by: Yufeng Mei, et al.
Published: (2022-07-01)

How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer’s disease risk? A novel integrative model
by: Jaisalmer de Frutos Lucas, et al.
Published: (2023-01-01)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
by: Ikumi Tomizawa, et al.
Published: (2022-06-01)

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins
by: Manabu Niimi, et al.
Published: (2024-07-01)